Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome

BACKGROUND: Prostate cancer (PCa) is a major health problem worldwide. Taxol derivatives-based chemotherapies or immunotherapies are usually proposed depending on the symptomatic status of the patient. In the case of immunotherapy, tumors develop robust immune escape mechanisms that abolish any prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiraboschi, Carolina, Gentilini, Lucas, Velazquez, Carla, Corapi, Enrique, Jaworski, Felipe Martín, Garcia Garcia, José Daniel, Rondón, Yorfer, Chauchereau, Anne, Laderach, Diego José, Compagno, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725099/
https://www.ncbi.nlm.nih.gov/pubmed/33293356
http://dx.doi.org/10.1136/jitc-2020-001535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725099/
https://www.ncbi.nlm.nih.gov/pubmed/33293356
http://dx.doi.org/10.1136/jitc-2020-001535

Ejemplares similares